Details for Patent: 8,721,615
✉ Email this page to a colleague
Which drugs does patent 8,721,615 protect, and when does it expire?
Patent 8,721,615 protects FARXIGA and BYDUREON PEN and is included in two NDAs.
Protection for BYDUREON PEN has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has seven patent family members in four countries.
Summary for Patent: 8,721,615
Title: | Ampoule comprising an ampoule holder |
Abstract: | An ampoule including a casing, a facing side and a seal, wherein the casing has an outer diameter and the seal extends radially beyond the outer diameter and seals the facing side. |
Inventor(s): | Moser; Ulrich (Heimiswill, CH), Tschirren; Markus (Kirchberg, CH), Drunk; Annette (Bern, CH), Hirschel; Jurg (Aarau, CH), Kaenel; Celine (Zurich, CH), Mori; Kevin (Burgdorf, CH), Harris; Scott (San Diego, CA), Puddy; John (San Diego, CA), Chang; Victor (San Diego, CA) |
Assignee: | TecPharma Licensing AG (Burgdorf, CH) |
Application Number: | 12/951,772 |
Patent Claim Types: see list of patent claims | Delivery; Device; |
Drugs Protected by US Patent 8,721,615
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Astrazeneca Ab | FARXIGA | dapagliflozin | TABLET;ORAL | 202293-001 | Jan 8, 2014 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | |||
Astrazeneca Ab | FARXIGA | dapagliflozin | TABLET;ORAL | 202293-002 | Jan 8, 2014 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | |||
Astrazeneca Ab | BYDUREON PEN | exenatide synthetic | FOR SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS | 022200-002 | Feb 28, 2014 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 8,721,615
Foriegn Application Priority Data | ||
Foreign Country | Foreign Patent Number | Foreign Patent Date |
Germany | 10 2008 025 011 | May 24, 2008 |
International Family Members for US Patent 8,721,615
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Germany | 102008025011 | ⤷ Try a Trial | |||
European Patent Office | 2300079 | ⤷ Try a Trial | |||
European Patent Office | 2300081 | ⤷ Try a Trial | |||
Taiwan | 200948408 | ⤷ Try a Trial | |||
Taiwan | I478746 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |